METTL3 and esophageal squamous cell carcinoma: Moreover, analysis of clinical samples revealed that the expression of METTL3 was prominently increased in clinical ESCC tissues from three validation cohorts as compared to NATs (Fig. 3J–M and Supplementary Fig. S4).